A study of Acebrophylline (Ambroxol acephyllinate) for the treatment of bronchial diseases.
Phase of Trial: Phase I
Latest Information Update: 10 Mar 2016
At a glance
- Drugs Acebrophylline (Primary)
- Indications Bronchial disorders
- Focus Therapeutic Use
- 10 Mar 2016 New trial record
- 08 Mar 2016 According to a Hyundai Pharmaceutical media release, the company has submitted IND to SFDA. The trial is expected to begin in the end of 2014 and the product approval is expected in the middle of 2016.